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Abstract This study compares the distribution of car-
diovascular risk factors in different ethnic groups at high
risk of developing cardiovascular diseases within general
practices. A total of 430 patients (179 Dutch, 126 Turks, 50
Surinamese, 23 Moroccans, 23 Antilleans and 29 from
other ethnic groups) were included in the study. Data
collection consisted of questionnaires and physical and
clinical examinations. 54% was female. The mean age was
53.1 (sd 9.9) years. There were important ethnic differ-
ences in the distribution of cardiovascular risk factors.
Compared to the Dutch, ethnic minorities had significantly
greater odds of being diabetic (OR = 3.2–19.4); but were
less likely to smoke (OR = 0.10–0.53). Turkish individu-
als had a lower prevalence of hypercholesterolemia but
were 2.4 times more likely to be obese than the Dutch.
Hypertension was very common in all ethnic groups and no
significant ethnic differences were found. These findings
provide additional evidence of the need for tailored inter-
ventions for different ethnic groups in general practices.
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Introduction
People living in deprived neighbourhoods continue to be at
greater risk for developing cardiovascular diseases (CVD)
than the general population [1, 2]. In the Netherlands, as in
many European countries, people from ethnic minorities
form a large group of all people living in the most deprived
neighbourhoods. This group consists of Turks, Moroccans,
Surinamese, Antilleans, and many others, with marked
differences in cultural background, history and life style.
Similar to other western countries such as the USA and UK
[3–5] the overall cardiovascular mortality is generally
higher among ethnic minority groups than in the general
population [6].
Although several international studies have shown that
both prevention through life style changes and improved
treatment regimes play an important role in reducing car-
diovascular diseases and related cardiovascular risk factors
[7–10], the question rises whether ethnic specific inter-
ventions are more appropriate, since most studies have
been conducted in white populations [11, 12] and the
effectiveness of general interventions is disappointing in
ethnic minority groups [13, 14]. An important step in
investigating whether interventions tailored to various
ethnic minority groups are necessary to efficiently reduce
cardiovascular risk, is the assessment and comparison of
the cardiovascular risk profile of high-risk people from
different ethnic backgrounds.
According to a systematic review of Uitewaal et al. [15]
some major risk factors such as diabetes, smoking and
obesity, are more prevalent among Turkish and Moroccan
minorities than among the native Dutch population. Further
information about the distribution of modifiable cardio-
vascular risk factors in individuals of different ethnic
origins, is warranted.
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We conducted a study in a multi-ethnic population at
high risk of developing CVD to identify ethnic specific
cardiovascular risk factors within general practices.
Methods
Data were collected in 2003 from patients from three pri-
mary healthcare centres representing five general practices
(18 general practitioners) situated in deprived neighbour-
hoods of two major Dutch cites: Rotterdam and The Hague.
Area deprivation in the Netherlands is defined according to
an index, based on income and number of people depen-
dant on social benefits and level of urbanisation [16].
Study Population
We selected 1131 patients aged 30–70 years living in
deprived neighbourhoods, with one or more registered
cardiovascular risk factors (smoking, hypertension, hyper-
cholesterolemia, diabetes mellitus, family history of CVD,
or history of CVD) from the electronic GP medical records
to participate in a randomised controlled trial to reduce
cardiovascular risk. In total 536 patients signed informed
consent for the trial. Reasons for exclusion were: not
reached after repeated home visits (n = 193) and subject
refusal to participate (n = 402). Main reasons for refusal
were: not interested (n = 114), language problems
(n = 72), treated by a specialist (n = 49), had no time
(n = 45) and other reasons (n = 122) like planned to go
abroad for longer than six months and being too ill to
participate. Complete questionnaires and physical and
biochemical measurements were available from 430
patients.
Physical and Biochemical Measurements
Participants underwent a limited physical examination
including blood pressure, weight and height measurements,
which took place at their home by trained research assis-
tants. Systolic and diastolic blood pressures were measured
with a validated automatic sphygmomanometer, with par-
ticipants in sitting position and after they had been resting
for at least 5 min. The average of two measurements, taken
with a 10 min interval was used for the analysis. Weight
was measured with subjects wearing light clothes and no
shoes; height was measured without shoes to the nearest
cm. The body mass index (BMI) was determined by
dividing the weight in kg by the square of height in meters.
Blood samples were taken at the laboratory to assess
fasting glucose, HbAc1 and lipid profile (total and HDL
cholesterol and triglycerides). LDL-cholesterol was calcu-
lated using the Friedewald formula.
Questionnaire
A research assistant interviewed participants in their pre-
ferred language at the participant’s home. The questionnaire
was translated from Dutch into Turkish and Moroccan
Arabic. For other groups who speak and understand the
Dutch language (very) well, we used the Dutch question-
naire. Where necessary (i.e. in case of some Antilleans and
Surinamese from Hindustani origin) interviewers from the
same ethnic background were involved.
We used a structured questionnaire that included ques-
tions on demographic and socioeconomic characteristics
(educational level, income and working status), family and
personal history of CVD, health behaviour (physical
activity, diet, smoking and alcohol consumption) and
medication use.
Definitions of Ethnicity and Cardiovascular Risk
Factors
Ethnicity was defined according to the country of birth of
the respondents. We considered five ethnic groups: indig-
enous Dutch, Turkish, Moroccan, Surinamese, and
Antilleans. A sixth group comprised small numbers of
individuals from different other origins.
The cardiovascular risk factors were defined as follows:
– Diabetes mellitus: was considered present if the
measured fasting glucose C7.0 mmol/l [17]; and/or
patients currently used diabetes medication.
– Hypertension: patients were considered as hypertensive
if the systolic blood pressure was C140 mm Hg and/or
diastolic blood pressure was C90 mm Hg [18] and/or
currently used anti-hypertensive medications.
– Hypercholesterolemia was defined as total cholesterol
C5.0 mmol/l [19]; and/or current use of lipid-lowering
medication.
– Smoking behaviour: participants reported whether they
smoked (current smokers) and if they had stopped
whether they had smoked at least 100 cigarettes during
their lifetime (ex-smokers) [20].
– Overweight and obesity: we classified participants as
overweight in case of a BMI between 25 kg/m2 and
30 kg/m2 and as obese if their BMI was C30 kg/m2 [21].
– 10-year absolute risk of developing CVD was deter-
mined using the Framingham risk function [22]. Two
10-year risk-thresholds were considered: C10% and
C20%.
Statistical Analysis
To compare the differences in cardiovascular risk factors
between the six ethnic groups, we used Chi-square tests for
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categorical variables. Differences in continuous variables
were assessed using one-way analysis of variance.
We examined the associations between ethnicity and
cardiovascular risk factors and cardiovascular risk using
multiple logistic regression analysis to adjust for differ-
ences in age and gender between the ethnic groups. We
used SPSS software version 12.0 for data analysis.
Ethics
The study protocol was approved by the local ethics
committee of the Erasmus Medical Centre of Rotterdam.
All participants gave their informed consent to participate.
Results
The response rate was 47%. There were no remarkable
differences between responders and non-responders in
background characteristics or known cardiovascular risk
factors (Table 1). Responders were on average two years
younger than non-responders (53. 2 ± 9.7 years versus
55.5 ± 9.7 years) and there were fewer diabetics among
responders than among non-responders (31% and 39%).
In Table 2 we present the background characteristics of
the various ethnic groups with completed risk profile.
Large differences between the ethnic groups were present
according to age, educational level and working status. All
ethnic minority groups were on average four to eight years
younger than Dutch people. A greater proportion of
Moroccans than other ethnic groups had no school educa-
tion. There were fewer employed individuals among the
Turks and more retired people among the Dutch compared
to the other ethnic groups.
The results of the clinical measurements showed that the
levels of HbAc1, fasting glucose and triglycerides were
significantly different across the ethnic groups (Table 3).
The diastolic, but not systolic blood pressure was signifi-
cantly different according to ethnicity. There were
significant differences in the BMI, with Turkish people
having the highest BMI. The Dutch had the highest 10-year
absolute risk to develop CVD.
Table 4 shows that there were important ethnic differ-
ences in the prevalence of diabetes, hypercholesterolemia,
smoking behaviour and obesity. Moroccan individuals had
the greatest proportion of diabetics (74%) while the Dutch
had the lowest proportion (17%). The prevalence of
hypercholesterolemia was highest in Dutch (86%) and of
obesity in the Turkish participants (61%). There were more
smokers among Dutch (41%) than other ethnic groups.
Further analysis of the gender difference in smoking
behaviour showed that the greatest number of smokers
were Turkish males and Dutch females (data not shown).
Hypertension was very common in all ethnic groups and no
significant ethnic differences were found.
Ethnicity was a determinant of the age and gender
adjusted prevalence of all investigated cardiovascular risk
factors, except for hypertension and for the absolute risk
for CVD (Table 5). Turks, Surinamese, Antilleans, and
Moroccans had a clear increased risk of diabetes compared
to the Dutch (odds ratios were 3.3, 6.7, 3.2, and 19.4
respectively). Obesity was clearly associated with a Turk-
ish background: Turkish individuals were 2.4 times more
likely to be obese than Dutch. All ethnic groups were less
likely to smoke than the Dutch. Almost all non-Dutch
ethnic groups had a lower prevalence of hypercholester-
olemia than the Dutch, but this association was statistically
significant for the Turks only. Although the Dutch had a
higher 10-year CVD risk than ethnic minority groups, after
adjusting for age and gender, most ethnic minority groups
were more likely to have a 10-year absolute cardiovascular
risk C 10% and C 20% than the Dutch. However, this
association was not statistically significant.
Table 1 Characteristicsa of non-responders (n = 595), responders
(n = 536) and responders with complete cardiovascular risk profile
(n = 430)
Non-
responders
(n = 595)
Responders
(n = 536)
Complete CV
risk profile
(n = 430)
Gender
Males 51a 46 46
Females 49 54 54
Age (mean (sd)) 55.5 (9.7) 53.2 (9.7) 53.1 (9.9)
30–39 years 9 9 10
40–49 years 18 28 28
50–59 years 36 35 33
60 + years 38 26 28
Ethnicity
Dutch 38 40 42
Turkish 22 27 29
Moroccan 4 6 5
Surinamese 12 12 12
Antillean 2 5 5
Other 22 10 8
Cardiovascular risk factors (based on data from GP records)
Diabetes 39 31 29
Hypertension 49 44 44
Hypercholesterolemia 20 22 23
Smoking 27 32 30
History of CVD 33 31 32
Family history of
CVD
15 17 19
a All values are proportions, unless stated otherwise
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Discussion
Our results showed that individuals from ethnic minorities
have a higher prevalence of diabetes and obesity but a
lower prevalence of hypercholesterolemia and reported
smoking than the native Dutch population, while the
prevalence of hypertension seemed comparable between
ethnic groups. Furthermore, in each ethnic group different
combinations of cardiovascular risk factors were found.
The finding that diabetes was more prevalent among
some ethnic groups than among the native population was
also reported in other national and international
Table 2 Demographic characteristics of the ethnic groups participating in the study (n (%))
Dutch
n = 179
Turkish
n = 126
Moroccan
n = 23
Surinamese
n = 50
Antillean
n = 23
Other
n = 29
Total
n = 430
Overall
significance
Females 88 (49) 76 (60) 15 (65) 29 (58) 15 (65) 9 (31) 232 (54) P = 0.028
Age (mean ( sd)) 57.5(8.7) 48.8 (9.3) 49.5(10.3) 51.7 (9.0) 52.2 (8.0) 53.0 (8.5) 53.1 (9.9) P = 0.0001
Age categories
30–39 years 6 (3) 24 (19) 4 (17) 6 (12) 2 (9) 2 (7) 44 (10) P = 0.0001
40–49 years 31 (17) 50 (40) 11 (48) 17 (34) 7 (30) 5 (17) 121 (28)
50–59 years 66 (40) 31 (25) 3 (13) 17 (34) 10 (44) 16 (55) 143 (33)
60 + years 76 (43) 21 (17) 5 (22) 10 (20) 4 (17) 6 (21) 122 (28)
Highest educational levela
No 16 (10) 39 (32) 17 (74) 7 (15) 3 (14) 4 (17) 86 (21) P = 0.0001
Low 63 (38) 62 (51) 2 (9) 13 (27) 3 (14) 8 (33) 151 (37)
Lower secondary 63 (38) 10 (8) 2 (9) 17 (35) 12 (57) 6 (25) 110 (27)
Higher secondary 13 (8) 8 (7) 0 (0) 8 (17) 2 (10) 5 (21) 36 (9)
Higher 13 (9) 3 (3) 2 (9) 3 (6) 1 (5) 1 (4) 22 (5)
Working status
Employed 62 (35) 21 (17) 8 (35) 22 (44) 13 (57) 10 (35) 136 (32) P = 0.0001
Housewife/man 43 (24) 58 (46) 12 (52) 14 (28) 5 (22) 6 (21) 138 (32)
Retired 42 (24) 7 (6) 2 (9) 3 (6) 0 (0) 2 (7) 56 (13)
Incapacitated for
work
22 (12) 9 (7) 1 (4) 3 (6) 4 (17) 8 (28) 47 (11)
Unemployed 10 (6) 31 (25) 0 (0) 8 (16) 1 (4) 3 (10) 53 (12)
Public health care
insuranceb
153 (86) 116 (95) 23 (100) 44 (88) 19 (86) 27 (93) 382 (90) P = 0.054
Missing values: a 25, b 5
Table 3 Biochemical and physical characteristics of the study population by ethnicity (mean (sd))
Dutch
n = 179
Turkish
n = 126
Moroccan
n = 23
Surinamese
n = 50
Antillean
n = 23
Other
n = 29
Total
n = 430
Overall
significance
HbAc1 (%) 6.1 (0.9) 6.4 (1.4) 7.7 (1.8) 7.2 (1.9) 6.7 (1.5) 6.5 (1.1) 6.5 (1.4) P = 0.0001
Fasting glucose (mmol/l) 6.1 (2.0) 6.4 (2.2) 8.8 (3.8) 7.6 (3.2) 6.6 (2.1) 6.8 (2.2) 6.6 (2.4) P = 0.0001
Total cholesterol (mmol/l) 5.6 (1.0) 5.4 (1.0) 5.4 (0.8) 5.2 (0.9) 5.7 (1.2) 5.7 (1.4) 5.5 (1.0) P = 0.083
HDL-cholesterol (mmol/l) 1.4 (0.5) 1.3 (0.4) 1.2 (0.4) 1.3 (0.3) 1.5 (0.4) 1.3 (0.4) 1.4 (0.4) P = 0.060
LDL-cholesterol (mmol/l) 3.4 (0.9) 3.2 (0.9) 3.1 (0.9) 3.2 (0.8) 3.6 (1.0) 3.4 (1.4) 3.3 (1.0) P = 0.362
Triglycerides (mmol/l) 1.8 (1.1) 2.0 (1.2) 2.2 (1.9) 1.6 (0.7) 1.5 (0.6) 2.1 (1.5) 1.9 (1.2) P = 0.037
Systolic blood pressure
(mm Hg)
142.5 (23.4) 139.8 (22.9) 145.3 (23.5) 149.3 (27.0) 142.8 (20.3) 136.9 (26.7) 142.3 (23.9) P = 0.186
Diastolic blood pressure
(mm Hg)
84.3 (11.3) 87.4 (11.9) 91.3 (14.1) 90.9 (12.9) 87.2 (11.6) 83.4 (15.5) 86.4 (12.4) P = 0.002
BMI (kg/m2) 29.2 (5.6) 32.0 (5.4) 30.6 (4.7) 28.7 (6.2) 31.4 (5.7) 30.8 (5.6) 30.3 (5.7) P = 0.0001
10-year CVD risk (%) 21.6 (13.7) 14.5 (11.5) 15.8 (12.3) 17.2 (11.2) 14.9 (7.8) 17.6 (10.2) 18.0 (12.6) P = 0.0001
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epidemiological studies [15, 23–26]. In the studies by
Cappucio et al. [23], Bhopal et al. [24], and Anand et al.
[25], South Asians in the UK and Canada had a higher
prevalence of diabetes/glucose intolerance than people of
European origin; and in the study by Winkleby et al. [26]
Black and Mexican American women had higher diabetes
prevalence than white women. This phenomenon can be
explained by genetic susceptibility and/or environmental
factors such as the adoption of a western diet, obesity and
physical inactivity [27].
We did not find indications for a higher prevalence of
hypertension in ethnic minority people than in the Dutch
population, although the diastolic blood pressure was rel-
atively higher among ethnic minorities than among the
Dutch. This result is similar to other studies showing no
clear differences between Turkish or Moroccan people and
the native Dutch population [15]. There are some indica-
tions of a higher prevalence among Surinamese (a mixed
group of African descent and people originated from South
Asia) than in Dutch [28], which is in accordance with
international studies that reported a higher prevalence of
hypertension in South Asians [29] and people from African
origin [30] compared to white populations in the UK and
USA respectively.
Hypercholesterolemia, based on the level of total cho-
lesterol, was generally higher in Dutch than in most ethnic
minority people. This is in line with the limited data
comparing the Turkish or Moroccan ethnic groups with the
Dutch [15] while no such information is available for Su-
rinamese and Antilleans. On the other hand, the levels of
other lipid components were more disadvantageous (e.g.
high levels of triglycerides among Turks and Moroccans)
among some ethnic groups in our study than in the Dutch.
In general, ethnic comparisons of the lipid profiles remain
difficult because of the limited number of studies and
inconsistencies of the findings [15].
In line with previous studies [15, 23, 24] obesity was
more common among minority groups, particularly
Turkish people, than in the native population. The pro-
portion of obese individuals in our study also largely
exceeded national rates implying that obesity is a serious
health problem among people living in deprived
Table 4 Prevalence of cardiovascular risk factors by ethnicity (n (%))
Dutch
n = 179
Turkish
n = 126
Moroccan
n = 23
Surinamese
n = 50
Antillean
n = 23
Other
n = 29
Total
n = 430
Overall
significance
Diabetes 30 (17) 42 (33) 17 (74) 26 (52) 8 (35) 8 (28) 131 (31) P = 0.0001
Hypertension 135 (75) 83 (66) 15 (65) 40 (80) 17 (74) 19 (66) 309 (72) P = 0.295
Hypercholesterolemia 154 (86) 90 (71) 16 (70) 40 (80) 20 (87) 19 (66) 339 (79) P = 0.011
Current smokers 79 (44) 43 (34) 2 (9) 9 (18) 6 (26) 9 (31) 148 (34) P = 0.001
Ex-smoker 66 (37) 25 (20) 3 (13) 13 (26) 6 (26) 13 (49) 126 (29) P = 0.004
Overweight
(25 B BMI \ 30 kg/m2)
72 (41) 38 (31) 9 (39) 18 (38) 5 (23) 9 (33) 151 (36) P = 0.380
Obesity (BMI C 30 kg/m2) 68 (39) 74 (61) 11 (49) 16 (33) 13 (59) 16 (59) 198 (48) P = 0.001
10-year CVD risk C 10% 140 (78) 69 (55) 14 (61) 34 (68) 17 (74) 23 (79) 297 (69) P = 0.001
10-year CVD risk C 20% 82 (46) 30 (24) 6 (26) 17 (34) 6 (26) 11 (38) 152 (35) P = 0.003
Table 5 Association of cardiovascular risk factors and 10 year absolute risk with ethnicity, adjusted for age and gender (odds ratio (OR) & 95%
confidence interval (CI))
Turkish Moroccan Surinamese Antillean Other
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Diabetes 3.31 (1.83–5.98)* 19.35 (6.71–55.82)* 6.67 (3.28–13.57)* 3.24 (1.24–8.49)* 2.11 (0.84–5.31)
Hypertension 1.07 (0.61–1.87) 1.01 (0.38–2.71) 1.92 (0.86–4.31) 1.27 (0.46–3.54) 0.79 (0.33–1.89)
Hypercholesterolemia 0.42 (0.22–0.77)* 0.37 (0.14–1.02) 0.66 (0.29–1.50) 1.07 (0.29–3.91) 0.33 (0.14–0.81)*
Smoking 0.53 (0.31–0.90)* 0.10 (0.02–0.45)* 0.23 (0.10–0.52)* 0.41 (0.15–1.12) 0.42 (0.18–1.00)
Obesity 2.37 (1.41–3.97) 1.37 (0.56–3.37) 0.76 (0.38–1.52) 2.13 (0.85–5.34) 2.48 (1.07–5.74)*
10-year CVD risk C 10% 1.18 (0.60–2.33) 2.13 (0.64–7.15) 1.54 (0.63–3.75) 1.92 (0.56–6.37) 1.74 (0.47–6.37)
10-year CVD risk C 20% 1.17 (0.59–2.32) 1.17 (0.27–5.03) 1.68 (0.71–3.97) 1.12 (0.35–3.57) 0.91 (0.33–2.48)
* Statistically significant
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neighbourhoods and in particular among ethnic minority
women. Native Dutch had a higher prevalence of reported
smoking than non-Dutch groups, but Turkish men had a
higher prevalence than Dutch men. This is in agreement
with other Dutch studies showing a high smoking prev-
alence among Turkish men [15]. The low prevalence of
smoking among ethnic minority women in our study is
also consistent with previous national and international
studies [15, 23–25].
The 10-year cardiovascular risk was higher in Dutch, but
the age and gender adjusted 10-year risk was somewhat
higher in ethnic minorities, which could be attributed to
their unfavourable cardiovascular risk factors. Intervention
activities are recommended according to the 10-year CVD
risk [19]. This approach could result in under treatment of
young ethnic minority groups with high levels of (modifi-
able) risk factors and over treatment of elderly Dutch
people [31].
Some limitations of the present study should be men-
tioned. First, the nature of the study population. Because
data collection took place among a population at risk of
developing CVD, this means that our results can not be
generalised to the general population due the inclusion of
high-risk individuals only. However, our findings point to
the same direction as previous studies in the general pop-
ulation, and show the necessity of tailoring interventions
also in this high-risk group. In addition, for the prevention
of CVD, evidence has shown that targeting high-risk
groups is more beneficial than targeting the general popu-
lation [32]. The response rate was 47% which is
satisfactory when taking into account previous studies
conducted in multi-ethnic patient populations in the
Netherlands [15]. We have no reason to believe that the
cardiovascular risk factors are likely to be different in the
individuals examined compared to those who were not
because responders and non-responders in our study had a
comparable cardiovascular risk profile according to GP
medical records.
Since we firstly selected patients from the electronic GP
medical records, our findings could be biased because of
differences in access to the general practice or in the reg-
istration of risk factors between the general practitioners.
Regarding access to the general practice, in the Nether-
lands (almost) all patients are registered in a general
practice and therefore have equal access regardless of
where they live. Concerning registration of risk factors, we
used all available medical information from the GP med-
ical records to identify potential high-risk patients. This
yielded similar proportions of potentially high-risk indi-
viduals per general practitioner, indicating that an effect of
differences in registration between the general practitioners
is unlikely.
This study shows the heterogeneity of people living in
deprived neighbourhoods in terms of ethnicity, demo-
graphic and socioeconomic characteristics, and particularly
the distribution of cardiovascular risk factors which
emphasizes the need for tailoring interventions to different
ethnic groups at risk of developing CVD. Notably, atten-
tion should be given to diabetes intervention and education,
since diabetes is one of the most prevalent cardiovascular
risk factors among all ethnic minorities at risk of devel-
oping CVD, particularly the Moroccans. Among the Turks
emphasis should be put on interventions aimed at reducing
the high prevalence of obesity as well as smoking while
among the Dutch hypercholesterolemia and smoking
should be given higher priority than other risk factors. We
found no ethnic differences in hypertension; however,
taking into account previous studies we suggest that
interventions with regard to Surinamese and Antilleans
should take hypertension into consideration.
In conclusion, the present study shows that the different
cardiovascular risk factors were not uniformly distributed
among ethnic groups in the Netherlands and provides
additional evidence of the need to tailor interventions for
different ethnic groups in general practices.
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